Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback